Providing for disclosure by health insurers of the use of artificial intelligence-based algorithms in the utilization review process.
Impact
If passed, HB 1663 would significantly impact state laws governing health insurance practices, particularly in relation to the utilization review process. The bill will necessitate that health insurers provide clear documentation regarding the algorithms they use, which could vary based on the technology and methodologies employed. This legislative change aims to reduce ambiguity around coverage determinations and empower consumers by providing them with better insights into how healthcare decisions are made.
Summary
House Bill 1663 aims to enhance transparency in the health insurance sector by mandating that insurers disclose how they use artificial intelligence-based algorithms during their utilization review processes. This requirement is designed to ensure that patients and healthcare providers are aware of the decision-making criteria that affect coverage decisions and treatment options. By making this information available, the bill seeks to improve accountability and foster trust in the healthcare system as AI technologies increasingly influence medical decisions.
Sentiment
General sentiment surrounding HB 1663 appears to be supportive among consumer advocacy groups and professionals in the healthcare sector who argue that transparency is critical in maximizing patient rights and fair access to care. However, concerns have been expressed by some insurance companies regarding the feasibility and potential costs associated with implementing such disclosures, indicating a split perspective among stakeholders involved.
Contention
A notable point of contention associated with the bill is the balance between innovation in healthcare through AI and the need for regulation to protect consumers. Critics may argue that excessive regulation could stifle the advancement of beneficial technologies in healthcare, while supporters assert that without proper oversight, AI could lead to biased or unfair outcomes in treatment and coverage decisions. The discussions surrounding HB 1663 raise important questions about ethical considerations in AI and the healthcare industry's responsibility to maintain transparency in all facets of patient care.
Relating to the use of artificial intelligence-based algorithms by health benefit plan issuers, utilization review agents, health care providers, and physicians.
Providing for artificial intelligence in facilities, for artificial intelligence use by insurers and for artificial intelligence use by MA or CHIP managed care plans; imposing duties on the Department of Health, the Insurance Department and the Department of Human Services; and imposing penalties.
Providing for artificial intelligence in facilities, for artificial intelligence use by insurers and for artificial intelligence use by MA or CHIP managed care plans; imposing duties on the Department of Health, the Insurance Department and the Department of Human Services; and imposing penalties.
Relates to the use of artificial intelligence by insurers and clinical peer reviewers for utilization review; establishes additional notice requirements for adverse determinations.
Relates to the use of artificial intelligence by insurers and clinical peer reviewers for utilization review; establishes additional notice requirements for adverse determinations.